AB007. Neurotensin derived from cancer stroma contributes to castration resistance via promoting neuroendocrine transdifferentiation

Por Zhu, Shimiao, Shang, Zhiqun, Tian, Hao, Flores-Morales, Amilcar, Niu, Yuanjie
Publicado no Transl Androl Urol (2016)

AB188. Vasohibin-1 and microvessel density predict prognosis in clear cell renal cell carcinoma

Por Tian, Hao, Zhu, Shimiao, Li, Xing, Wen, Simeng, Shang, Zhiqun, Niu, Yuanjie
Publicado no Transl Androl Urol (2016)

Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer

Por Wen, Simeng, Chang, Hong-Chiang, Tian, Jing, Shang, Zhiqun, Niu, Yuanjie, Chang, Chawnshang
Publicado no Am J Pathol (2015)

Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer

Por Wang, Jiang, Li, Gang, Li, Bo, Song, Hualin, Shang, Zhiqun, Jiang, Ning, Niu, Yuanjie
Publicado no Oncol Lett (2017)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival

Por Li, Gang, Yu, Jianpeng, Song, Hualin, Zhu, Shimiao, Sun, Libin, Shang, Zhiqun, Niu, Yuanjie
Publicado no BMC Cancer (2017)

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals

Por Wang, Zhun, Xie, Hui, Guo, Linpei, Cai, Qiliang, Shang, Zhiqun, Jiang, Ning, Niu, Yuanjie
Publicado no Cancer Manag Res (2017)

Increased CK5/CK8-Positive Intermediate Cells with Stromal Smooth Muscle Cell Atrophy in the Mice Lacking Prostate Epithelial Androgen Receptor

Por Niu, Yuanjie, Wang, Juan, Shang, Zhiqun, Huang, Shu-Pin, Shyr, Chih-Rong, Yeh, Shuyuan, Chang, Chawnshang
Publicado em 2011

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies

Por Zhu, Shimiao, Tang, Yang, Li, Kai, Shang, Zhiqun, Jiang, Ning, Nian, Xuewu, Sun, Libin, Niu, Yuanjie
Publicado em 2013

Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9(®) enhances BCG efficacy to better suppress bladder cancer progression

Por Shang, Zhiqun, Li, Yanjun, Zhang, Minghao, Tian, Jing, Han, Ruifa, Shyr, Chih-Rong, Messing, Edward, Yeh, Shuyuan, Niu, Yuanjie, Chang, Chawnshang
Publicado no Mol Cancer Ther (2015)

Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer

Por Shang, Zhiqun, Li, Yanjun, Hsu, Iawen, Zhang, Minghao, Tian, Jing, Wen, Simeng, Han, Ruifa, Messing, Edward M., Chang, Chawnshang, Niu, Yuanjie, Yeh, Shuyuan
Publicado no Oncotarget (2016)

A switch from CD44(+) cell to EMT cell drives the metastasis of prostate cancer

Por Shang, Zhiqun, Cai, Qiliang, Zhang, Minghao, Zhu, Shimiao, Ma, Yuan, Sun, Libin, Jiang, Ning, Tian, Jing, Niu, Xiaodan, Chen, Jiatong, Sun, Yinghao, Niu, Yuanjie
Publicado no Oncotarget (2014)

Erratum: OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo

Por Iglesias-Gato, Diego, Chuan, Yin-Choy, Jiang, Ning, Svensson, Charlotte, Bao, Jing, Shang, Zhiqun, Paul, Indranil, Egevad, Lars, Kessler, Benedikt M, Wikström, Pernilla, Niu, Yuanjie, Flores-Morales, Amilcar
Publicado no Mol Cancer (2015)